Medical Condition News

RSS

Experimental drug that targets macrophages decreases cancer's growth

An experimental drug that targets macrophages, a type of immune cells, in the microenvironment surrounding the lethal brain tumor glioblastoma multiforme decreased the cancer's growth and extended survival of laboratory mice with the cancer, scientists will report on Tuesday Dec. 17, at the American Society for Cell Biology annual meeting in New Orleans.

16 Dec 2013

OncoSec Medical reports positive interim data from OMS-I100 Phase 2 trial for metastatic melanoma

OncoSec Medical Inc., a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy to treat solid tumors, today announced positive interim data from its ongoing Phase 2 trial of OMS-I100 in the treatment of metastatic melanoma. The results were presented by principal investigator Adil Daud, MD, at the Advances in Cancer Immunotherapy meeting at the University of California San Francisco.

16 Dec 2013

Cellular Biomedicine Group completes TC-DC Phase I clinical trial for hepatocellular carcinoma

Cellular Biomedicine Group, Inc., a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases, is pleased to announce that it has treated the final patient of its Phase I clinical trial which evaluates the safety and preliminary efficacy of TC-DC (Tumor Stem Cell Specific Dendritic Cell) therapy for hepatocellular carcinoma, the most common type of liver cancer.

16 Dec 2013

Janssen receives complete response letter for canagliflozin/metformin FDC therapy for type 2 diabetes

Janssen Research & Development, LLC (Janssen) today announced it has received from the U.S. Food and Drug Administration (FDA) a complete response letter regarding its New Drug Application (NDA) for a fixed-dose combination (FDC) of canagliflozin and immediate-release metformin to treat adults with type 2 diabetes.

16 Dec 2013

Drug abuse appears to foster brain changes that resemble schizophrenia

Teens who were heavy marijuana users -- smoking it daily for about three years -- had abnormal changes in their brain structures related to working memory and performed poorly on memory tasks, reports a new Northwestern Medicine- study.

16 Dec 2013

Auxilium doses first patient in CCH Phase 2b study for treatment frozen shoulder syndrome

BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX in the U.S. and XIAPEX in the EU, today announced that its partner Auxilium Pharmaceuticals, Inc. has dosed the first patient in its Phase 2b study of collagenase clostridium histolyticum for the treatment of frozen shoulder syndrome (adhesive capsulitis).

16 Dec 2013

FDA accepts Shield Therapeutics' IND application to begin ST10 Phase 3 pivotal study for IDA treatment

Shield Therapeutics, an independent specialty pharmaceutical company focused on the development of mineral-derived hospital pharmaceuticals, today announces that the US Food and Drug Administration has accepted its Investigational New Drug application to initiate a Phase 3 pivotal study of ST10, its novel oral iron-replacement therapy, for the treatment of iron deficiency anaemia in pre-dialysis patients with chronic kidney disease. The Company plans to initiate the Phase 3 study in the US in H1 2014 and positive data would be the cornerstone of a subsequent NDA submission.

16 Dec 2013

Robotic trolley system helps overcome falling fear for patients who recovering from stroke, brain injury

The risk and fear of falling often affects patients who are recovering from a stroke, spinal cord or brain injury, and orthopaedic injuries, and that fear may inhibit their progress in rehabilitation.

16 Dec 2013

Diabetes most common among older men and those living in the South

About 8.8 percent of the privately insured population in 2012 had diabetes or was diagnosed as being at high risk for diabetes, up from 8.3 percent in 2011, but the rates of disease varied depending on age, gender and region of the country, says a new report from HCCI. In 2012, over one quarter of men between the ages of 55-64 and nearly one in 10 Southerners had diabetes or were at risk for diabetes.

16 Dec 2013

Research: Released prisoners seven times more likely to commit suicide than general population

Research on the mortality of released prisoners is sparse and what research has been conducted has mainly focused on drug-related causes of death. This is a systematic review to investigate the risk of suicide in recently released prisoners.

16 Dec 2013

Nucletron installs first Esteya electronic brachytherapy system for skin cancer treatment

The first Esteya electronic brachytherapy system in the United States has been installed at New York's Memorial Sloan-Kettering Cancer Center. Esteya by Nucletron, an Elekta company, is a new approach for skin cancer treatment that relies on a small, high dose rate (HDR) X-ray source to apply high precision radiotherapy directly to the cancer site.

From Elekta 16 Dec 2013

Prescription drug misuse and driving after using drugs on the rise among Ontario students

Alcohol consumption and smoking among Ontario students in grades 7-12 is at an all-time low; however recreational use of over-the-counter drugs is on the rise. Prescription drug misuse and driving after using drugs also remain elevated according to the 2013 Ontario Student Drug Use and Health Survey released by the Centre for Addiction and Mental Health.

16 Dec 2013

NIH Stroke Trials Network includes UC San Diego Health System as grant recipient

A network of 25 nationally recognized stroke centers has been created to rapidly address the three core features of stroke research and care: prevention, treatment and recovery. The regional coordinating centers, working with nearby satellite facilities, will span the country and have teams of researchers representing every stroke-related medical specialty, with the primary goal of bringing new therapies and strategies to the stroke community more rapidly.

16 Dec 2013

Researchers gather first direct evidence of how microbubbles cause blood clot's demise

Ultrasound-stimulated microbubbles have been showing promise in recent years as a non-invasive way to break up dangerous blood clots. But though many researchers have studied the effectiveness of this technique, not much was understood about why it works. Now a team of researchers in Toronto has collected the first direct evidence showing how these wiggling microbubbles cause a blood clot's demise. The team's findings are featured in the AIP Publishing journal Applied Physics Letters.

16 Dec 2013

Cornell engineers create smartCARD that uses smartphone's camera to read cholesterol level

With a new smartphone device, you can now take an accurate iPhone camera selfie that could save your life - it reads your cholesterol level in about a minute.

16 Dec 2013

IOF Young Investigator Awards presented to five researchers at 4th Asia-Pacific Osteoporosis Meeting

Today, the International Osteoporosis Foundation recognized the outstanding work of five young researchers from China, Chinese Taipei, Hong Kong, Malaysia and Pakistan.

16 Dec 2013

Exercise in middle age protects against sarcopenia and maintains muscle strength, physical performance

A cross-sectional study by investigators from Tokyo University has found that exercising in middle age is a protective factor against sarcopenia and effective in maintaining muscle strength and physical performance.

16 Dec 2013

Research suggests new way of treating asthma in obese people

Research conducted at Boston Children's Hospital indicates that obesity might cause asthma via factors in the immune system and suggests a new way of treating asthma in obese people—who often respond poorly to standard asthma medications. The study, conducted in a mouse model of asthma and in human lung fluid, was published online Dec. 15 by Nature Medicine.

16 Dec 2013

Researchers identify new method to predict outcomes in heart failure patients

Researchers at the George Washington University School of Medicine and Health Sciences (SMHS) and Johns Hopkins University School of Medicine have identified a new method to determine whether a patient's heart will fail, which in the future may help physicians better treat patients and tailor therapeutic interventions.

16 Dec 2013

Study could lead towards a personalised medicine for chemoresistant lymphomata

To date, tests have only been carried out on cells, but a piece of research conducted by the Department of Genetics at the UPV/EHU's Faculty of Medicine in collaboration with MD Anderson and the CNIO is opening up the door for the treatment of lymphoma types that have a lower survival rate. The study of the molecular characteristics of the tumours would enable molecules that are altered in a specific way to be identified and turned into new therapeutic targets that would improve the prognosis of patients with chemoresistant lymphomata.

16 Dec 2013

Medical Condition News

Experimental drug that targets macrophages decreases cancer's growth

OncoSec Medical reports positive interim data from OMS-I100 Phase 2 trial for metastatic melanoma

Cellular Biomedicine Group completes TC-DC Phase I clinical trial for hepatocellular carcinoma

Janssen receives complete response letter for canagliflozin/metformin FDC therapy for type 2 diabetes

Drug abuse appears to foster brain changes that resemble schizophrenia

Auxilium doses first patient in CCH Phase 2b study for treatment frozen shoulder syndrome

FDA accepts Shield Therapeutics' IND application to begin ST10 Phase 3 pivotal study for IDA treatment

Robotic trolley system helps overcome falling fear for patients who recovering from stroke, brain injury

Diabetes most common among older men and those living in the South

Research: Released prisoners seven times more likely to commit suicide than general population

Nucletron installs first Esteya electronic brachytherapy system for skin cancer treatment

Prescription drug misuse and driving after using drugs on the rise among Ontario students

NIH Stroke Trials Network includes UC San Diego Health System as grant recipient

Researchers gather first direct evidence of how microbubbles cause blood clot's demise

Cornell engineers create smartCARD that uses smartphone's camera to read cholesterol level

IOF Young Investigator Awards presented to five researchers at 4th Asia-Pacific Osteoporosis Meeting

Exercise in middle age protects against sarcopenia and maintains muscle strength, physical performance

Research suggests new way of treating asthma in obese people

Researchers identify new method to predict outcomes in heart failure patients

Study could lead towards a personalised medicine for chemoresistant lymphomata

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News